Literature DB >> 20391076

Challenges and coping styles of fathers as primary medical caretakers: a multicultural qualitative study.

Joshua Wolff1, Jenny Pak, Kathleen Meeske, J William Worden, Ernest Katz.   

Abstract

Research has focused heavily on mother's experiences of children with life-threatening illnesses. In contrast, fathers' experiences, especially among minorities, are scarcely discussed. This study examined the experiences of 15 fathers as primary medical caretakers of children diagnosed with cancer or sickle cell disease. Using a life story method, fathers completed semistructured interviews regarding their overall experiences. Data was analyzed using narrative analysis with multiple case studies. Results indicated single, low socioeconomic status, and immigrant fathers with limited English proficiencies were at highest risk for coping difficulties. This study also examined gender biases that men experienced and masculine norms in coping.

Entities:  

Mesh:

Year:  2010        PMID: 20391076     DOI: 10.1080/07347330903516902

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  3 in total

1.  Evaluation of the psychometric properties of the Pediatric Parenting Stress Inventory (PPSI).

Authors:  Katie A Devine; Charles E Heckler; Ernest R Katz; Diane L Fairclough; Sean Phipps; Sandra Sherman-Bien; Michael J Dolgin; Robert B Noll; Martha A Askins; Robert W Butler; Olle Jane Z Sahler
Journal:  Health Psychol       Date:  2013-04-01       Impact factor: 4.267

2.  Benefit finding in fathers of childhood cancer survivors: a retrospective pilot study.

Authors:  Molly A Hensler; Ernest R Katz; Lori Wiener; Roger Berkow; Avi Madan-Swain
Journal:  J Pediatr Oncol Nurs       Date:  2013 May-Jun       Impact factor: 1.636

3.  Stressors and Barriers to Services for Immigrant Fathers Raising Children with Developmental Disabilities.

Authors:  Nazilla Khanlou; Nida Mustafa; Luz Maria Vazquez; Nasim Haque; Karen Yoshida
Journal:  Int J Ment Health Addict       Date:  2015-09-01       Impact factor: 3.836

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.